Express News | BioXcel Therapeutics Inc Files for Resale of up to 5.1 Mln Shares by the Selling Stockholders - SEC Filing

Breakings05:46

Bioxcel Therapeutics Revises Executive Compensation Structure

TipRanksJan 8 21:18

Express News | BioXcel Therapeutics Inc : BofA Global Research Cuts to Underperform From Buy; Cuts Price Objective to $0.25 From $7

BreakingsJan 7 21:08

BofA Securities Downgrades BioXcel Therapeutics(BTAI.US) to Sell Rating, Announces Target Price $0.25

Futu NewsJan 7 20:36 · Ratings

Bank of America Securities Downgrades Bioxcel Therapeutics (BTAI) to a Sell

TipRanksJan 7 19:56 · Ratings

Canaccord Genuity Maintains Buy on BioXcel Therapeutics, Lowers Price Target to $5

BenzingaJan 6 20:22 · Ratings